Form 4: UMH Properties CEO Samuel Landy Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Samuel Landy, President and CEO of UMH Properties, reports changes in beneficial ownership of company stock, including acquisitions through dividend reinvestment.
Summary
- Samuel Landy, the President and CEO of UMH Properties, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- The report includes shares acquired through dividend reinvestment on September 16, 2024.
- Landy's direct ownership includes 1,154,825.85 shares, including shares held in a 401(k).
- Indirect ownership includes shares held by his spouse (11,009.75 shares), jointly with his spouse (44,200.25 shares), and through The Landy 2022 Family Trust (47,471.71 shares).
- He also has indirect ownership through his role as Co-Manager of EWL Grandchildren Fund LLC (48,000 shares).
- The report also details ownership of derivative securities, specifically options to purchase UMH Properties stock at various exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: This is a routine filing, so the sentiment is neutral. It simply reflects changes in ownership due to dividend reinvestment and existing option holdings.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the ownership stake of the CEO.
- It can influence investor perception of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 04/04/2018 | Date of options grant with exercise price of $15.04 and expiration date of 04/04/2027 |
| 01/19/2018 | Date of options grant with exercise price of $14.25 and expiration date of 01/19/2027 |
| 04/02/2019 | Date of options grant with exercise price of $13.09 and expiration date of 04/02/2028 |
| 03/21/2024 | Date of options grant with exercise price of $14.36 and expiration date of 03/21/2033 |
| 09/16/2024 | Date of dividend reinvestment. |
| 09/27/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.